Two patients can receive the same medication at the same dose and experience very different outcomes. One may benefit from treatment, another may develop side effects, and a third may not respond at all. One reason for these differences lies in our genes.
Pharmacogenetics, often shortened to PGx, is the study of how genetic differences influence the way people respond to medications. It brings together two fields of science: pharmacology, which looks at how medicines work in the body, and genetics, which looks at the information stored in our DNA.
Our genes carry the instructions for how the body functions, including instructions for many of the proteins and enzymes that help process medications once they enter the body. Because every person inherits a unique combination of genetic variants, these processes can work slightly differently from one person to the next.
Pharmacogenetics aims to understand these differences and how they affect medication response. By considering relevant genetic information alongside other clinical factors, healthcare professionals can make more informed decisions about medication choice and dosing.
In simple terms, pharmacogenetics helps answer an important question: Why does the same medication work differently for different people?
Before a medication can have its intended effect, it usually goes through several steps in the body, such as being absorbed, distributed, metabolized or excreted. Many of these steps are carried out by proteins and enzymes, and the instructions for building them come from our genes.
Not all medications follow the same route. Some are metabolized mainly in the liver, while others pass through the body largely unchanged and are removed by the kidneys or the digestive system. Metabolism is the process by which the body breaks down a medicine, typically in the liver to help the body use or eliminate it. Pharmacogenetics focuses primarily on medications that are metabolized in the liver, since this is where many of the genetically variable enzymes are active.
Because genes vary naturally from person to person, the activity of these liver enzymes can vary too. Some people process certain medications faster than expected, while others process them more slowly. These differences affect how much of a drug is present in the body, and for how long it stays active.
For example:
Depending on the situation, the dosage may need to be adjusted, or the patient may need to switch to a different medication altogether. These differences reflect how an individual’s body handles the medication, not a flaw in the treatment itself.
One of the main goals of pharmacogenetics is to help clarify how a patient’s genetic profile may influence their response to medication. This information can support more personalized treatment decisions and reduce some of the uncertainty that often comes with starting a new medication.
Finding the right medication sometimes takes trial and error, with adjustments to the drug, the dose, or the overall treatment plan. Pharmacogenetic information can help identify medications that are more or less likely to suit a particular patient, and it can offer guidance on whether a standard dose is likely to be appropriate. This supports a more informed approach to treatment selection from the start.
Pharmacogenetics can also help explain why some patients experience side effects while others do not. Since genetic differences influence how medications are processed, they can, in some cases, increase or decrease the likelihood of unwanted effects. Understanding this can support safer prescribing and more targeted monitoring when it is needed.
The relevance of pharmacogenetics spans many therapeutic areas. It is already applied in fields such as psychiatry, cardiovascular care, and pain management, where genetic factors are known to affect, how patients respond to treatment. As research continues, the number of medications and treatment areas with pharmacogenetic evidence keeps growing.
It is worth remembering that pharmacogenetics is only one part of the clinical picture. Medication decisions should always take into account other factors, such as age, medical history, organ function, coexisting conditions, and other medications a patient may be taking. Pharmacogenetics does not replace clinical expertise. It adds another layer of information that can help healthcare professionals make more personalized, informed decisions.
Ultimately, pharmacogenetics supports a broader shift toward personalized medicine. Rather than assuming a treatment will affect every patient in the same way, it helps account for individual differences, working toward the goal of matching the right treatment to the right patient.
